Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-292767

Chief Medical Officer sold 5,407 shares at $24.50 ($132,472)

  • Chief Medical Officer acquired 5,407 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Janku Filip · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Exercise or conversion : show line 1 in the form 10b5-1 +5,407 $13.41 $72,508 66,019 D
2026-06-30 Sale : show line 2 in the form 10b5-1 −5,407 $24.50 $132,472 60,612 D
Open-market sales · 5,407 sh · avg $24.50 · $132,472

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-30 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −5,407 81,093 D
Loading xslF345X06/ownership.xml…